Done sou Salè H1B

Akèy › Tit travay › Principal Statistical Programmer

Principal Statistical Programmer: Salè H-1B

292 aplikasyon kondisyon travay te itilize tit travay Principal Statistical Programmer. Salè baz medyàn ofri $142,000; mwatye mitan $129,068–$150,961.

Demann (LCA)292
Salè medyan ofri$142,000
Mwatye salè yo$129,068–$150,961
10yèm–90yèm pousantaj$105,631–$167,078

Avoka imigrasyon, rekritè oswa anplwayè? Mete sèvis ou an tèt paj sa a — $99 pou 30 jou →

Anplwayè yo

AnplwayèLCASalè medyan
IQVIA RDS Inc.43$153,075
Cytel Inc.36$137,589
Parexel International LLC26$147,420
Safety & Efficacy IT Solutions Inc.24$103,100
Regeneron Pharmaceuticals, Inc.16$150,729
Vertex Pharmaceuticals Incorporated15$146,501
Fortrea Inc.11$125,694
Pfizer Inc.9$142,000
Syneos Health, LLC8$137,218
Intone Networks, Inc.8$132,500
Labcorp Drug Development Inc.7$121,826
Seagen Inc.7$142,000
Pharmaceutical Research Associates, Inc.7$150,139
Softworld, LLC6$129,147
Alnylam US, Inc.5$170,000
Fortrea Inc. f/k/a LabCorp Drug Development Inc.4$141,500
TechData Service Company LLC4$148,000
Motion Recruitment Partners, LLC4$142,230
Precision Medicine Group, LLC4$147,518
Jazz Pharmaceuticals, Inc.3$159,650
Springworks Therapeutics Operating Company3$190,000
Spartan Solutions Inc.3$93,580
Clinvia LLC3$155,000
Sarepta Therapeutics, Inc.2$149,500
Agios Pharmaceuticals, Inc.2$132,464
Ipsen Bioscience, Inc.2$169,592
Servier Bio-Innovation LLC2$161,407
Travere Therapeutics, Inc.2$139,398
Syndax Pharmaceuticals, Inc2$188,800
Everest Clinical Research Corporation2$157,326
Novusscientia LLC1—
Terbium Technologies INC1$106,000
Fortrea Inc. (Formerly d/b/a LabCorp Drug Development, Inc.)1$123,000
Intellectt, Inc.1$117,000
Ephicacy Consulting Group, Inc1$140,000
Shionogi, Inc.1$128,000
Intone Networks, Inc. d/b/a Intone1$150,000
HSquare IT Solutions Inc1$79,747
Roche Molecular Systems, Inc.1$115,898
WCG Clinical, Inc.1$124,800
Nixon Technologies LLC1$68,286
Olema Pharmaceuticals, Inc.1$190,000
Ipsen Biopharmaceuticals, Inc.1$169,592
Medidata Solutions, Inc.1$182,571
Krystal Biotech Inc.1$150,000
Ocugen OpCo, Inc.1$113,776
Feather Technologies Inc1$137,093
ITSyntax Inc1$140,000
Calsoft Labs Inc1$104,000
Vitalminds Inc.1$141,000
Vertex Pharmaceuticals (Clinical) LLC1$149,200
Symbiance Inc.1$130,000

Pa nivo salè

Nivo revniSalè medyan
Nivo I (antre)$84,950
Nivo II (kalifye)$128,300
Nivo III (eksperyans)$140,379
Nivo IV (plen kompetans)$148,607

Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.

Pa ane fiskal

Ane fiskalLCASalè medyan
FY202369$140,000
FY202469$142,000
FY202568$135,778
FY202677$149,200

Vil yo

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Sep 30, 2026).